Johan Askling

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Jag är professor i reumatologi/reumatisk sjukdomsepidemiologi vid Karolinska Institutet, samt reumatolog och överläkare vid Karolinska Universitetssjukhuset.

Utvalda publikationer

Article: THE BMJ. 2013;346:f1939
Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
Raaschou P; Simard JF; Holmqvist M; Askling J
Article: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA). 2012;308(13):1350-1356
Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization
Holmqvist ME; Neovius M; Eriksson J; Mantel A; Wallberg-Jonsson S; Jacobsson LTH; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2012;64(1):42-52
Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis
Ljung L; Simard JF; Jacobsson L; Rantapaa-Dahlqvist S; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(11):3180-3189
Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor α Therapies Does the Risk Change With the Time Since Start of Treatment?
Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Coster L; Geborek P; Jacobsson LT; Lindblad S; Rantapaa-Dahlqvist S; Saxne T; Klareskog L
Review: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(6):707-712
Swedish registers to examine drug safety and clinical issues in RA
Askling J; Fored CM; Geborek P; Jacobsson LTH; van Vollenhoven R; Feltelius N; Lindblad S; Klareskog L

Artiklar

Article: JOURNAL OF CROHN'S AND COLITIS. 2024;18(9):1371-1380
Spondyloarthritis in First-Degree Relatives and Spouses of Patients with Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study from Sweden
Shrestha S; Brand JS; Osooli M; Eriksson C; Schoultz I; Askling J; Jess T; Montgomery S; Olen O; Halfvarson J
Article: GENERAL HOSPITAL PSYCHIATRY. 2024;89:23-31
Association between inflammatory joint disease and severe or treatment-resistant depression: population-based cohort and case-control studies in Sweden
Brenner P; Askling J; Hagg D; Brandt L; Stang P; Reutfors J
Article: RHEUMATOLOGY. 2024;63(5):1221-1229
Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis
Sysojev AO; Saevarsdottir S; Diaz-Gallo L-M; Silberberg GN; Alfredsson L; Klareskog L; Baecklund E; Bjorkman L; Kastbom A; Rantapaa-Dahlqvist S; Turesson C; Jonsdottir I; Stefansson K; Frisell T; Padyukov L; Askling J; Westerlind H
Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(4):446-456
Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study
Exarchou S; Di Giuseppe D; Klingberg E; Sigurdardottir V; Wedren S; Lindstroem U; Turesson C; Jacobsson LTH; Askling J; Wallman JK
Article: RHEUMATOLOGY. 2024;63(3):751-764
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries
Linde L; Ornbjerg LM; Georgiadis S; Rasmussen SH; Lindstrom U; Askling J; Michelsen B; Di Giuseppe D; Wallman JK; Gudbjornsson B; Love TJ; Nordstrom DC; Yli-Kerttula T; Nekvindova L; Vencovsky J; Iannone F; Cauli A; Loft AG; Glintborg B; Laas K; Rotar Z; Tomsic M; Macfarlane GJ; Moller B; van de Sande M; Codreanu C; Nissen MJ; Birlik M; Erten S; Santos MJ; Vieira-Sousa E; Hetland ML; Ostergaard M
Article: JOURNAL OF INTERNAL MEDICINE. 2024;295(3):313-321
Disease-modifying antirheumatic drugs and risk of thyroxine-treated autoimmune thyroid disease in patients with rheumatoid arthritis
Waldenlind K; Delcoigne B; Saevarsdottir S; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(3):277-287
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation
Pertsinidou E; Saevarsdottir S; Manivel VA; Klareskog L; Alfredsson L; Mathsson-Alm L; Hansson M; Cornillet M; Serre G; Holmdahl R; Skriner K; Jakobsson P-J; Westerlind H; Askling J; Roennelid J
Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;64:152240
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study
Simon TA; Suissa S; Boers M; Hochberg MC; Skovron ML; Askling J; Michaud K; Strangfeld A; Pedro S; Frisell T; Meissner Y; Dominique A; Gomez A
Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;64:152313
Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study
Simon TA; Suissa S; Skovron ML; Frisell T; Askling J; Michaud K; Pedro S; Strangfeld A; Meissner Y; Boers M; Hoffman V; Dominique A; Gomez A; Hochberg MC
Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(2):177-183
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies
Simon TA; Dong L; Suissa S; Michaud K; Pedro S; Hochberg M; Boers M; Askling J; Frisell T; Strangfeld A; Meissner Y; Khaychuk V; Dominique A; Maldonado MA
Article: RMD OPEN. 2023;9(4):e003648
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden
Bower H; Frisell T; di Giuseppe D; Delcoigne B; Lindstrom U; Turesson C; Chatzidionysiou K; Lindqvist E; Knight A; Forsblad-d'Elia H; Askling J
Article: RMD OPEN. 2023;9(4):e003714
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study
Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
Article: RMD OPEN. 2023;9(4):e003630
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis
Bower H; Frisell T; di Giuseppe D; Delcoigne B; Askling J
Article: RMD OPEN. 2023;9(4):e003111
Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritis
Lindqvist J; Askling J; Lampa J
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2023;58(10):1028-1040
Microscopic colitis and risk of incident rheumatoid arthritis: A nationwide population-based matched cohort study
Bergman D; Roelstraete B; Sun J; Ebrahimi F; Askling J; Ludvigsson JF
Article: PSYCHOLOGICAL MEDICINE. 2023;53(15):7300-7308
Maternal rheumatoid arthritis and risk of autism in the offspring
Yin W; Norrback M; Levine SZ; Rivera N; Buxbaum JD; Zhu H; Yip B; Reichenberg A; Askling J; Sandin S
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(12):3132-3142
Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study
Olen O; Smedby KE; Erichsen R; Pedersen L; Halfvarson J; Hallqvist-Everhov A; Askling J; Ekbom A; Sachs MC; Sorensen HT; Ludvigsson JF
Article: RHEUMATOLOGY. 2023;62(10):3391-3399
Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application
Barbulescu A; Sjolander A; Delcoigne B; Askling J; Frisell T
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2023;58(7):692-703
Increasing healthcare costs in inflammatory bowel disease 2007-2020 in Sweden
Everhov A; Soederling J; Befrits G; Khalili H; Broems G; Neovius M; Askling J; Halfvarson JF; Ludvigsson J; Olen O; SWIBREG SG
Article: SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION. 2023;83(5):330-335
Calprotectin, a sensitive marker of inflammation, is robustly assessed in plasma from patients with early or established rheumatoid arthritis by use of different laboratory methods
Hammer HB; Pedersen SL; Jonsson MKK; Mathsson-Alm L; Gehring I; Sexton J; Haavardsholm EAA; Askling J
Article: RMD OPEN. 2023;9(3):e003027
Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts
Westerlind H; Glintborg B; Hammer HB; Saevarsdottir S; Krogh NS; Hetland ML; Hauge E-M; Tejada IM; Sexton J; Askling J
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2023;115:55-61
How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway
Delcoigne B; Provan SA; Kristianslund EK; Askling J; Ljung L
Article: JOURNAL OF RHEUMATOLOGY. 2023;50(8):1009-1019
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment
Ornbjerg LM; Rugbjerg K; Georgiadis S; Rasmussen SH; Lindstrom U; Pavelka K; Yilmaz N; Favalli EG; Nissen MJ; Michelsen B; Vieira-Sousa E; Jones GT; Ionescu R; Relas H; Sanchez-Piedra C; Tomsic M; Geirsson AJ; van der Horst-Bruinsma I; Askling J; Loft AG; Nekvindova L; Direskeneli H; Iannone F; Ciurea A; Fagerli KM; Santos MJ; Macfarlane GJ; Codreanu C; Eklund K; Pombo-Suarez M; Rotar Z; Gudbjornsson B; Rusman T; Ostergaard M; Hetland ML
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(4):374-384
Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register
Wallman JK; Alenius G-M; Klingberg E; Sigurdardottir V; Wedren S; Exarchou S; Lindstrom U; Di Giuseppe D; Askling J; Jacobsson LTH
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(7):911-919
Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study
Huss V; Bower H; Hellgren K; Frisell T; Askling J; ARTIS G
Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY (EJE). 2023;38(7):809-819
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Qin C; Diaz-Gallo L-M; Tang B; Wang Y; Nguyen T-D; Harder A; Lu Y; Padyukov L; Askling J; Hagg S
Article: NATURE COMMUNICATIONS. 2023;14(1):3453
Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethality
Oddsson A; Sulem P; Sveinbjornsson G; Arnadottir GM; Steinthorsdottir V; Halldorsson G; Atlason BO; Oskarsson G; Helgason H; Nielsen HS; Westergaard DA; Karjalainen J; Katrinardottir H; Fridriksdottir RB; Jensson B; Tragante VA; Ferkingstad E; Jonsson H; Gudjonsson S; Beyter D; Moore KHS; Thordardottir H; Kristmundsdottir S; Stefansson O; Rantapaa-Dahlqvist S; Sonderby IE; Didriksen MA; Stridh P; Haavik J; Tryggvadottir L; Frei O; Walters GB; Kockum I; Hjalgrim H; Olafsdottir T; Selbaek G; Nyegaard M; Erikstrup C; Brodersen T; Saevarsdottir S; Olsson T; Nielsen KR; Haraldsson A; Bruun MT; Hansen TF; Steingrimsdottir T; Jacobsen RLT; Lie R; Djurovic S; Alfredsson L; Lopez de Lapuente Portilla A; Brunak S; Melsted PV; Halldorsson B; Saemundsdottir J; Magnusson OT; Padyukov L; Banasik K; Rafnar T; Askling J; Klareskog L; Pedersen OB; Masson G; Havdahl A; Nilsson BA; Andreassen O; Daly M; Ostrowski SR; Jonsdottir I; Stefansson H; Holm H; Helgason A; Thorsteinsdottir U; Stefansson KF; Gudbjartsson D
Article: JOURNAL OF RHEUMATOLOGY. 2023;50(6):781-788
The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017
Exarchou S; Wallman JK; Di Giuseppe D; Klingberg E; Sigurdardottir V; Wedren S; Lindstrom U; Turesson C; Jacobsson LTH; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(6):820-828
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries
Glintborg B; Di Giuseppe D; Wallman JK; Nordstrom DC; Gudbjornsson B; Hetland ML; Askling J; Grondal G; Sokka T; Provan SA; Michelsen B; Kristianslund EK; Dreyer L; Love TJ; Lindstrom U
Article: RHEUMATOLOGY. 2023;62(6):2106-2112
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis
Westerlind H; Kastbom A; Ronnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Skriner K; Bang H; Klareskog L; Saevarsdottir S; Lundberg K; Gronwall C; Askling J
Article: AMERICAN HEART JOURNAL. 2023;259:42-51
Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction
Faxen J; Benson L; Mantel A; Savarese G; Hage C; Dahlstrom U; Askling J; Lun LH; Andersson DC
Article: ACR OPEN RHEUMATOLOGY. 2023;5(5):277-284
Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional Analyses
Delcoigne B; Horne A; Askling J; Askling J
Article: RMD OPEN. 2023;9(2):e002883
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study
Lindstrom U; di Giuseppe D; Exarchou S; Alenius G-M; Olofsson T; Klingberg E; Jacobsson L; Askling J; Wallman JK
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(5):601-610
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
Frisell T; Bower H; Morin M; Baecklund E; Di Giuseppe D; Delcoigne B; Feltelius N; Forsblad-d'Elia H; Lindqvist E; Lindstroem U; Askling J
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(2):111-117
Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis
Molander V; Bower H; Askling J
Article: RMD OPEN. 2023;9(1):e002924
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers
Delcoigne B; Kopp TI; Arkema EV; Hellgren K; Provan SA; Relas H; Aaltonen K; Trokovic N; Gudbjornsson B; Grondal G; Klami Kristianslund E; Lindhardsen J; Dreyer L; Askling J
Article: RMD OPEN. 2023;9(1):e002753
Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from Sweden
Bengtsson K; Askling J; Lorentzon M; Rosengren B; Deminger A; Klingberg E; Jacobsson L; Forsblad-d'Elia H
Article: RHEUMATOLOGY AND THERAPY. 2023;10(1):201-223
Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases
Salinas CA; Louder A; Polinski J; Zhang TC; Bower H; Phillips S; Song Y; Rashidi E; Bosan R; Chang H-C; Foster N; Gershenson B; Yamanaka H; Kishimoto M; Tanaka Y; Fischer P; Zhu B; Faries D; Mai X; Doherty BT; Grelaud A; Thurin NH; Askling J; Deberdt W
Article: JOURNAL OF INTERNAL MEDICINE. 2023;293(2):246-258
Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection
Hedberg P; Granath F; Bruchfeld J; Askling J; Sjoholm D; Fored M; Farnert A; Naucler P
Article: RHEUMATOLOGY. 2023;62(2):647-658
Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries
Glintborg B; Di Giuseppe D; Wallman JK; Provan SA; Nordstrom D; Hokkanen A-M; Osterlund J; Kristianslund E; Kvien TK; Gudbjornsson B; Hetland ML; Michelsen B; Jacobsson L; Askling J; Lindstrom U
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(2):189-197
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis
Molander V; Bower H; Frisell T; Delcoigne B; Di Giuseppe D; Askling J
Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2022;117(12):1971-1981
Risk of Juvenile Idiopathic Arthritis and Rheumatoid Arthritis in Patients With Celiac Disease: A Population-Based Cohort Study
Doyle JB; Lebwohl B; Askling J; Forss A; Green PHR; Roelstraete B; Soderling J; Ludvigsson JF
Article: RMD OPEN. 2022;8(2):e002700
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study
Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
Article: RMD OPEN. 2022;8(2):e002776
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study
Cordtz RL; Askling J; Delcoigne B; Smedby KE; Baecklund E; Ballegaard C; Isomaki P; Aaltonen K; Gudbjornsson B; Love TJ; Provan SA; Michelsen B; Sexton J; Dreyer L; Hellgren K
Article: RHEUMATOLOGY. 2022;61(12):4741-4751
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis
Nissen M; Delcoigne B; Di Giuseppe D; Jacobsson L; Hetland ML; Ciurea A; Nekvindova L; Iannone F; Akkoc N; Sokka-Isler T; Fagerli KM; Santos MJ; Codreanu C; Pombo-Suarez M; Rotar Z; Gudbjornsson B; Van der Horst-Bruinsma I; Loft AG; Moeller B; Mann H; Conti F; Cetin GY; Relas H; Michelsen B; Ribeiro PA; Ionescu R; Sanchez-Piedra C; Tomsic M; Geirsson AJ; Askling J; Glintborg B; Lindstroem U
Article: RHEUMATOLOGY. 2022;61(11):4286-4296
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration
Delcoigne B; Provan SA; Hammer HB; Di Giuseppe D; Frisell T; Glintborg B; Grondal G; Gudbjornson B; Hetland ML; Michelsen B; Nordstrom D; Relas H; Askling J
Article: JOURNAL OF CROHN'S AND COLITIS. 2022;16(10):1540-1550
Association Between Inflammatory Bowel Disease and Spondyloarthritis: Findings from a Nationwide Study in Sweden
Shrestha S; Brand JS; Jaras J; Schoultz I; Montgomery S; Askling J; Ludvigsson JF; Olen O; Halfvarson J
Article: RHEUMATOLOGY. 2022;61(10):3952-3962
Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data
Barbulescu A; Askling J; Chatzidionysiou K; Forsblad-d'Elia H; Kastbom A; Lindstrom U; Turesson C; Frisell T
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2022;75(4):480-484
Colorectal Cancer in Childhood-onset Inflammatory Bowel Disease: A Scandinavian Register-based Cohort Study, 1969-2017
Everhov AH; Ludvigsson JF; Jaras J; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sorensen HT; Olen O
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2022;56(7):1168-1182
Colorectal cancer in elderly-onset inflammatory bowel disease: A 1969-2017 Scandinavian register-based cohort study
Everhov AH; Erichsen R; Jaras J; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sorensen HT; Olen O
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2022;112(4):836-845
Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational Data
Barbulescu A; Askling J; Saevarsdottir S; Kim SC; Frisell T
Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022;56:152081
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration
Ornbjerg LM; Linde L; Georgiadis S; Rasmussen SH; Lindstrom U; Askling J; Michelsen B; Di Giuseppe D; Wallman JK; Pavelka K; Zavada J; Nissen MJ; Jones GT; Relas H; Pirila L; Tomsic M; Rotar Z; Geirsson AJ; Gudbjornsson B; Kristianslund EK; Horst-Bruinsma IVS; Loft AG; Laas K; Iannone F; Corrado A; Ciurea A; Santos MJ; Santos H; Codreanu C; Akkoc N; Gunduz OS; Glintborg B; Ostergaard M; Hetland ML
Article: RMD OPEN. 2022;8(2):e002465
Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking
Chatzidionysiou K; di Giuseppe D; Soderling J; Catrina A; Askling J
Article: RHEUMATOLOGY. 2022;61(9):3799-3807
European bio-naive spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response
Christiansen SN; Ornbjerg LM; Rasmussen SH; Loft AG; Askling J; Iannone F; Zavada J; Michelsen B; Nissen M; Onen F; Santos MJ; Pombo-Suarez M; Relas H; Macfarlane GJ; Tomsic M; Codreanu C; Gudbjornsson B; Van der Horst-Bruinsma I; Di Giuseppe D; Glintborg B; Gremese E; Pavelka K; Kristianslund EK; Ciurea A; Akkoc N; Barcelos A; Sanchez-Piedra C; Peltomaa R; Jones GT; Rotar Z; Ionescu R; Grondal G; Van de Sande MGH; Laas K; Ostergaard M; Hetland ML
Article: RHEUMATOLOGY. 2022;61(9):3647-3656
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries
Di Giuseppe D; Lindstrom U; Aaltonen K; Relas H; Provan S; Gudbjornsson B; Hetland ML; Askling J; Kauppi M; Geirsson AJ; Chatzidionysiou K; Jorgensen TS; Dreyer L; Michelsen B; Jacobsson L; Glintborg B
Article: RHEUMATOLOGY. 2022;61(9):3596-3605
Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden
Di Giuseppe D; Lindstrom U; Bower H; Delcoigne B; Frisell T; Chatzidionysiou K; Sjowall C; Lindqvist E; Askling J
Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):203
Neither low social support nor low decision latitude at work is associated with disease remission among patients with rheumatoid arthritis: results from the Swedish EIRA study
Hedenstierna L; Hedstrom AK; Klareskog L; Di Giuseppe D; Alfredsson L; Askling J; Ernestam S; Saevarsdottir S; Ljung L
Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):185
Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?
Sysojev AO; Frisell T; Delcoigne B; Saevarsdottir S; Askling J; Westerlind H
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2022;56(3):491-500
Age determines the risk of familial inflammatory bowel disease-A nationwide study
Halfvarson JF; Ludvigsson JF; Bresso F; Askling J; Sachs MC; Olen O
Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(8):1085-1095
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset
Saevarsdottir S; Stefansdottir L; Sulem P; Thorleifsson G; Ferkingstad E; Rutsdottir G; Glintborg B; Westerlind H; Grondal G; Loft IC; Sorensen SB; Lie BA; Brink M; Arlestig L; Arnthorsson AO; Baecklund E; Banasik K; Bank S; Bjorkman LI; Ellingsen T; Erikstrup C; Frei O; Gjertsson I; Gudbjartsson DF; Gudjonsson SA; Halldorsson GH; Hendricks O; Hillert J; Hogdall E; Jacobsen S; Jensen DV; Jonsson H; Kastbom A; Kockum I; Kristensen S; Kristjansdottir H; Larsen MH; Linauskas A; Hauge E-M; Loft AG; Ludviksson BR; Lund SH; Markusson T; Masson G; Melsted P; Moore KHS; Munk H; Nielsen KR; Norddahl GL; Oddsson A; Olafsdottir TA; Olason PI; Olsson T; Ostrowski SR; Horslev-Petersen K; Rognvaldsson S; Sanner H; Silberberg GN; Stefansson H; Sorensen E; Sorensen IJ; Turesson C; Bergman T; Alfredsson L; Kvien TK; Brunak S; Steinsson K; Andersen V; Andreassen OA; Rantapaa-Dahlqvist S; Hetland ML; Klareskog L; Askling J; Padyukov L; Pedersen OB; Thorsteinsdottir U; Jonsdottir I; Stefansson K
Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(6):789-797
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries
Delcoigne B; Ljung L; Provan SA; Glintborg B; Hetland ML; Gron KL; Peltomaa R; Relas H; Turesson C; Gudbjornsson B; Michelsen B; Askling J
Article: RHEUMATOLOGY. 2022;61(5):1810-1818
Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice
Huss V; Bower H; Wadstrom H; Frisell T; Askling J
Article: ARTHRITIS CARE AND RESEARCH. 2022;74(5):748-758
One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses
Glintborg B; Lindstrom U; Di Giuseppe D; Provan SA; Gudbjornsson B; Hetland ML; Michelsen B; Wallman JK; Aaltonen K; Hokkanen A-M; Nordstrom D; Jorgensen TS; Hansen RL; Geirsson AJ; Gron KL; Krogh NS; Askling J; Kristensen LE; Jacobsson LTH
Article: RHEUMATOLOGY. 2022;61(3):1228-1232
Juvenile idiopathic arthritis, marriage and parenthood: a nationwide matched cohort study
Bruze G; Askling J; Horne A; Neovius M
Article: HEART. 2022;108(6):467-473
Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden
Rossides M; Kullberg S; Grunewald J; Eklund A; Di Giuseppe D; Askling J; Arkema EV
Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(3):433-439
Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?
Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Askling J
Article: RMD OPEN. 2022;8(1):e002018
Allergic conditions and risk of rheumatoid arthritis: a Swedish case-control study
Kronzer VL; Westerlind H; Alfredsson L; Crowson CS; Klareskog L; Holmqvist M; Askling J
Article: RMD OPEN. 2021;7(3):e001987
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision
Bower H; Frisell T; di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindstrom U; Turesson C; Sjowall C; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(11):1410-1418
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration
Lindstrom U; Di Giuseppe D; Delcoigne B; Glintborg B; Moller B; Ciurea A; Pombo-Suarez M; Sanchez-Piedra C; Eklund K; Relas H; Gudbjornsson B; Love TJ; Jones GT; Codreanu C; Ionescu R; Nekvindova L; Zavada J; Atas N; Yolbas S; Fagerli KM; Michelsen B; Rotar Z; Tomsic M; Iannone F; Santos MJ; Avila-Ribeiro P; Ornbjerg LM; Ostergaard M; Jacobsson LTH; Askling J; Nissen MJ
Article: RESPIRATORY MEDICINE. 2021;188:106624
Risk of acute myocardial infarction in sarcoidosis: A population-based cohort study from Sweden
Rossides M; Kullberg S; Grunewald J; Eklund A; Di Giuseppe D; Askling J; Arkema EV
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(11):1445-1452
Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter?
Lindstrom U; Bengtsson K; Olofsson T; Di Giuseppe D; Glintborg B; Forsblad-d'Elia H; Jacobsson LTH; Askling J
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2021;56(10):1152-1162
Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population: a nationwide register-based cohort study 2002-2017
Ludvigsson JF; Holmgren J; Grip O; Halfvarson J; Askling J; Sachs MC; Olen O
Article: JOURNAL OF RHEUMATOLOGY. 2021;48(10):1512-1518
Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis
Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordstrom D; Peltomaa R; Aaltonen K; Trokovic N; Kristianslund EK; Kvien TK; Provan SA; Gudbjornsson B; Grondal G; Dreyer L; Kristensen LE; Jorgensen TS; Jacobsson LTH; Askling J
Article: RHEUMATOLOGY. 2021;60(8):3635-3645
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis
Lindstrom U; Glintborg B; Di Giuseppe D; Jorgensen TS; Gudbjornsson B; Gron KL; Provan SA; Michelsen B; Hetland ML; Wallman JK; Nordstrom D; Trokovic N; Love TJ; Krogh NS; Askling J; Jacobsson LTH; Kristensen LE
Article: RHEUMATOLOGY. 2021;60(8):3760-3769
Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control study
Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
Article: RHEUMATOLOGY. 2021;60(8):keaa828--3668
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study
Hellgren K; Ballegaard C; Delcoigne B; Cordtz R; Nordstrom D; Aaltonen K; Gudbjornsson B; Love TJ; Provan SA; Sexton J; Zobbe K; Kristensen LE; Askling J; Dreyer L
Article: JOURNAL OF RHEUMATOLOGY. 2021;48(8):1243-1250
Tuberculosis in Biologic-naive Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics
Sundbaum JK; Arkema EV; Bruchfeld J; Jonsson J; Askling J; Baecklund E
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(8):1086-1093
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindstrom U; Turesson C; Sjowall C; Askling J
Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021;39(4):879-882
Rheumatoid arthritis autoantibodies and their association with age and sex
Pertsinidou E; Manivel VA; Westerlind H; Klareskog L; Alfredsson L; Mathsson-Alm L; Hansson M; Saevatsdottir S; Askling J; Ronnelid J
Article: ACR OPEN RHEUMATOLOGY. 2021;3(7):457-463
What Is the Persistence to Methotrexate in Rheumatoid Arthritis, and Does Machine Learning Outperform Hypothesis-Based Approaches to Its Prediction?
Westerlind H; Maciejewski M; Frisell T; Jelinsky SA; Ziemek D; Askling J
Article: JOURNAL OF CROHN'S AND COLITIS. 2021;15(6):980-987
Women's Earnings are more Affected by Inflammatory Bowel Disease than Men's: A Register-Based Swedish Cohort Study
Everhov AH; Bruze G; Soderling J; Askling J; Halfvarson J; Westberg K; Malmborg P; Nordenvall C; Ludvigsson JF; Olen O
Article: RHEUMATOLOGY. 2021;60(6):2725-2734
Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study
Bengtsson K; Forsblad-d'Elia H; Deminger A; Klingberg E; Dehlin M; Exarchou S; Lindstrom U; Askling J; Jacobsson LTH
Article: RHEUMATOLOGY. 2021;60(5):2217-2222
Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquine
Miller H; Wallman JK; Petersson IF; Saevarsdottir S; Soderlng J; Ernestam S; Askling J; van Vollenhoven R; Neovius M
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50(3):178-182
Social stressors and risk of rheumatoid arthritis and their relationship to known modifiable risk factors: results from the Swedish EIRA study
Hedenstierna L; Opava CH; Askling J; Jiang X; Ernestam S; Alfredsson L; Klareskog L; Saevarsdottir S
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2021;30(5):886-894
Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study
Erichsen R; Olen O; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sorensen HT
Article: ARTHRITIS CARE AND RESEARCH. 2021;73(5):658-665
Findings on Coronary Angiographies in Patients With Rheumatoid Arthritis and Ischemic Heart Disease: Are They Different From Patients Without Rheumatoid Arthritis?
Holmqvist M; Mantel A; Wallberg-Jonsson S; James S; Jernberg T; Askling J
Article: RESPIROLOGY. 2021;26(5):452-460
Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective 'target trial' emulated with Swedish real-world data
Rossides M; Kullberg S; Di Giuseppe D; Eklund A; Grunewald J; Askling J; Arkema EV
Article: CLINICAL RHEUMATOLOGY. 2021;40(4):1321-1329
Characteristics and outcome of a first acute myocardial infarction in patients with ankylosing spondylitis
Sodergren A; Askling J; Bengtsson K; Forsblad-d'Elia H; Jernberg T; Lindstrom U; Ljung L; Mantel A; Jacobsson LTH
Article: LIVER INTERNATIONAL. 2021;41(3):545-553
Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers
Hagstrom H; Ndegwa N; Jalmeus M; Ekstedt M; Posserud I; Rorsman F; Nyhlin N; Klintman D; Werner M; Marschall H-U; Askling J; Stal P
Article: GUT. 2021;70(2):297-308
Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden
Axelrad JE; Olen O; Sachs MC; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sorensen HT; Ludvigsson JF
Article: RHEUMATOLOGY. 2021;60(2):820-828
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries
Courvoisier DS; Chatzidionysiou K; Mongin D; Lauper K; Mariette X; Morel J; Gottenberg J-E; Bergstra SA; Suarez MP; Codreanu C; Kvien TK; Santos MJ; Pavelka K; Hetland ML; Askling J; Turesson C; Kubo S; Tanaka Y; Iannone F; Choquette D; Nordstrom DC; Rotar Z; Lukina G; Gabay C; Van Vollenhoven R; Finckh A
Article: RHEUMATOLOGY. 2021;60(2):809-819
Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype
Hellgren K; Di Giuseppe D; Smedby KE; Sundstrom C; Askling J; Baecklund E
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(2):169-175
Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden
Molander V; Bower H; Frisell T; Askling J
Article: RHEUMATOLOGY. 2021;60(1):140-146
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study
Hansen RL; Jorgensen TS; Dreyer L; Hetland ML; Glintborg B; Askling J; Di Giuseppe D; Jacobsson LTH; Wallman JK; Nordstrom D; Aaltonen K; Kristianslund EK; Kvien TK; Provan SA; Gudbjornsson B; Love TJ; Kristensen LE
Article: CLINICAL EPIDEMIOLOGY. 2021;13:21-41
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
Ludvigsson JF; Appelros P; Askling J; Byberg L; Carrero J-J; Ekstrom AM; Ekstrom M; Smedby KE; Hagstrom H; James S; Jarvholm B; Michaelsson K; Pedersen NL; Sundelin H; Sundquist K; Sundstrom J
Article: ARTHRITIS & RHEUMATOLOGY. 2021;73(1):61-68
Respiratory Diseases as Risk Factors for Seropositive and Seronegative Rheumatoid Arthritis and in Relation to Smoking
Kronzer VL; Westerlind H; Alfredsson L; Crowson CS; Nyberg F; Tornling G; Klareskog L; Holmqvist M; Askling J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;105(6):779-785
Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
Baecklund F; Ekberg S; Rosenquist R; Askling J; Eloranta S; Smedby KE
Article: RMD OPEN. 2020;6(3):e001463
Is rheumatoid arthritis a risk factor for acute coronary syndrome also among individuals at elevated risk, such as individuals presenting with acute chest pain?
Svensson P; Bergstrom M; Discacciati A; Ljung L; Jernberg T; Frick M; Linder R; Askling J
Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY (EJE). 2020;35(11):1087-1097
Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case-control study
Rossides M; Kullberg S; Askling J; Eklund A; Grunewald J; Di Giuseppe D; Arkema EV
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(10):1205-1210
Validity of administrative codes associated with cirrhosis in Sweden
Bengtsson B; Askling J; Ludvigsson JF; Hagstrom H
Article: ARTHRITIS & RHEUMATOLOGY. 2020;72(10):1658-1667
Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis
Westerlind H; Ronnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson P-J; Skriner K; Klareskog L; Saevarsdottir S; Askling J
Article: RMD OPEN. 2020;6(3):e001280
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration.
Michelsen B; Lindström U; Codreanu C; Ciurea A; Zavada J; Loft AG; Pombo-Suarez M; Onen F; Kvien TK; Rotar Z; Santos MJ; Iannone F; Hokkanen A-M; Gudbjornsson B; Askling J; Ionescu R; Nissen MJ; Pavelka K; Sanchez-Piedra C; Akar S; Sexton J; Tomsic M; Santos H; Sebastiani M; Österlund J; Geirsson AJ; Macfarlane G; van der Horst-Bruinsma I; Georgiadis S; Brahe CH; Ørnbjerg LM; Hetland ML; Østergaard M
Article: RMD OPEN. 2020;6(2):e001363
How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers
Chatzidionysiou K; Delcoigne B; Frisell T; Hetland ML; Glintborg B; Dreyer L; Cordtz R; Zobbe K; Nordstrom D; Trokovic N; Aaltonen K; Provan SA; Grondal G; Gudbjornsson B; Askling J
Article: EUROPEAN RESPIRATORY JOURNAL. 2020;56(3):2000767
Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study
Rossides M; Kullberg S; Eklund A; Di Giuseppe D; Grunewald J; Askling J; Arkema EV
Article: RHEUMATOLOGY. 2020;59(9):2455-2461
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis
Michelsen B; Ornbjerg LM; Kvien TK; Pavelka K; Nissen MJ; Nordstrom D; Santos MJ; Koca SS; Askling J; Rotar Z; Gudbjornsson B; Codreanu C; Loft AG; Kristianslund EK; Mann HF; Ciurea A; Eklund KK; Vieira-Sousa E; Yazici A; Jacobsson L; Tomsic M; Love TJ; Ionescu R; van der Horst-Bruinsma IE; Iannone F; Pombo-Suarez M; Jones GT; Hyldstrup LH; Krogh NS; Hetland ML; Ostergaard M
Article: NATURE. 2020;584(7822):619-623
FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease
Saevarsdottir S; Olafsdottir TA; Ivarsdottir EV; Halldorsson GH; Gunnarsdottir K; Sigurdsson A; Johannesson A; Sigurdsson JK; Juliusdottir T; Lund SH; Arnthorsson AO; Styrmisdottir EL; Gudmundsson J; Grondal GM; Steinsson K; Alfredsson L; Askling J; Benediktsson R; Bjarnason R; Geirsson AJ; Gudbjornsson B; Gudjonsson H; Hjaltason H; Hreidarsson AB; Klareskog L; Kockum I; Kristjansdottir H; Love TJ; Ludviksson BR; Olsson T; Onundarson PT; Orvar KB; Padyukov L; Sigurgeirsson B; Tragante V; Bjarnadottir K; Rafnar T; Masson G; Sulem P; Gudbjartsson DF; Melsted P; Thorleifsson G; Norddahl GL; Thorsteinsdottir U; Jonsdottir I; Stefansson K
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2020;52(4):655-668
Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden
Khalili H; Everhov AH; Halfvarson J; Ludvigsson JF; Askling J; Myrelid P; Soderling J; Olen O; Neovius M
Article: RMD OPEN. 2020;6(2):e001201
Gastrointestinal perforations in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs in Sweden: a nationwide cohort study
Barbulescu A; Delcoigne B; Askling J; Frisell T
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2020;52(1):143-154
Inflammatory bowel disease and pancreatic cancer: a Scandinavian register-based cohort study 1969-2017
Everhov AH; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sorensen HT; Olen O
Article: RMD OPEN. 2020;6(2):e001282
Does autoimmune thyroid disease affects rheumatoid arthritis disease activity or response to methotrexate?
Waldenlind K; Delcoigne B; Saevarsdottir S; Askling J
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2020;49(3):225-232
Population-based study of patients with primary Sjogren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences
Vasaitis L; Nordmark G; Theander E; Backlin C; Smedby KE; Askling J; Ronnblom L; Sundstrom C; Baecklund E
Article: ANNALS OF NEUROLOGY. 2020;87(5):688-699
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Alping P; Askling J; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Vrethem M; Olsson T; Piehl F; Frisell T
Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):566-572
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden
Kopp TI; Delcoigne B; Arkema EV; Jacobsen RK; Magyari M; Ibfelt EH; Locht H; Sellebjerg F; Cordtz RL; Jensen DV; Askling J; Dreyer L
Article: RMD OPEN. 2020;6(1):e001197
Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort study
Westerlind H; Delcoigne B; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):581-586
Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors
Wadstrom H; Pettersson A; Smedby KE; Askling J
Article: THE LANCET GASTROENTEROLOGY AND HEPATOLOGY. 2020;5(5):475-484
Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study
Olen O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sorensen HT; Ludvigsson JF
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2020;51(8):789-800
Adult height in patients with childhood-onset inflammatory bowel disease: a nationwide population-based cohort study
Mouratidou N; Malmborg P; Sachs MC; Askling J; Ekbom A; Neovius M; Smedby KE; Savendahl L; Ludvigsson JF; Olen O
Article: GUT. 2020;69(3):453-461
Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964-2014
Olen O; Askling J; Sachs MC; Neovius M; Smedby KE; Ekbom A; Ludvigsson JF
Article: THE LANCET. 2020;395(10218):123-131
Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study
Olen O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sorensen HT; Ludvigsson JF
Article: CLINICAL EPIDEMIOLOGY. 2020;12:273-285
Work Loss in Relation to Pharmacological and Surgical Treatment for Crohn's Disease: A Population-Based Cohort Study
Everhov A; Sachs M; Ludvigsson J; Khalili H; Askling J; Neovius M; Myrelid P; Halfvarson J; Nordenvall C; Soderling J; Olen O
Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(11):1536-1544
Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
Ornbjerg LM; Brahe CH; Askling J; Ciurea A; Mann H; Onen F; Kristianslund EK; Nordstrom D; Santos MJ; Codreanu C; Gomez-Reino J; Rotar Z; Gudbjornsson B; Di Giuseppe D; Nissen MJ; Pavelka K; Birlik M; Kvien T; Eklund KK; Barcelos A; Ionescu R; Sanchez-Piedra C; Tomsic M; Geirsson AJ; Loft AG; van der Horst-Bruinsma I; Jones G; Iannone F; Hyldstrup L; Krogh NS; Hetland ML; Ostergaard M
Article: INFLAMMATORY BOWEL DISEASES. 2019;25(10):1663-1673
Effects of Childhood-onset Inflammatory Bowel Disease on School Performance: A Nationwide Population-based Cohort Study Using Swedish Health and Educational Registers
Malmborg P; Mouratidou N; Sachs MC; Hammar U; Khalili H; Neovius M; Hjern A; Smedby KE; Ekbom A; Askling J; Ludvigsson JF; Olen O
Article: INFLAMMATORY BOWEL DISEASES. 2019;25(7):1237-1247
Work Loss Before and After Diagnosis of Crohn's Disease
Everhov AH; Khalili H; Askling J; Myrelid P; Ludvigsson JF; Halfvarson J; Nordenvall C; Neovius M; Soderling J; Olen O
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2019;17(7):1311-1322.e7
Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control Study
Axelrad JE; Olen O; Askling J; Lebwohl B; Khalili H; Sachs MC; Ludvigsson JF
Article: ARTHRITIS RESEARCH & THERAPY. 2019;21(1):128
Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice
Lindstrom U; Olofsson T; Wedren S; Qirjazo I; Askling J
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(3):207-212
Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjogren's syndrome
Vasaitis L; Nordmark G; Theander E; Backlin C; Smedby KE; Askling J; Ronnblom L; Sundstrom C; Baecklund E
Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(5):683-687
Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome
Westerlind H; Holmqvist M; Ljung L; Frisell T; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(3):320-327
Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden
Gron KL; Arkema EV; Glintborg B; Mehnert F; Ostergaard M; Dreyer L; Norgaard M; Krogh NS; Askling J; Hetland ML; Askling J; Klareskog L; Feltelius N; Baecklund E; Sjowall C; Rantapaa-Dahlqvist S; Forsblad-d'Elia H; Jacobsson L; Turesson C; Lindqvist E; Nisell R
Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2019;114(2):291-304
Fracture Risk in Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study From 1964 to 2014
Ludvigsson JF; Mahl M; Sachs MC; Bjork J; Michaelsson K; Ekbom A; Askling J; Backman A-S; Olen O
Article: GASTROENTEROLOGY. 2019;156(3):614-622
Increased Mortality of Patients With Childhood- Onset Inflammatory Bowel Diseases, Compared With the General Population
Olen O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
Article: RHEUMATOLOGY. 2019;58(8):1367-1377
Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register
Frisell T; Dehlin M; Di Giuseppe D; Feltelius N; Turesson C; Askling J; Ernestam S; Klareskog L; Nisell R; Baecklund E; Kastbom A; Jacobsson L; Lindqvist E; d'Elia HF; Rantapaa-Dahlqvist S
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2019;54(1):55-63
Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients
Everhov AH; Sachs MC; Malmborg P; Nordenvall C; Myrelid P; Khalili H; Elmberg M; Ekbom A; Askling J; Jakobsson G; Halfvarson J; Ludvigsson JF; Olen O
Article: RMD OPEN. 2019;5(2):e001055
Juvenile idiopathic arthritis and risk of cancer before and after the introduction of biological therapies
Horne A; Delcoigne B; Palmblad K; Askling J
Article: LIVER INTERNATIONAL. 2019;39(1):197-204
Cardiovascular risk factors in non-alcoholic fatty liver disease
Hagstrom H; Nasr P; Ekstedt M; Hammar U; Stal P; Askling J; Hultcrantz R; Kechagias S
Article: RMD OPEN. 2019;5(2):e001079
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naive patients with spondyloarthritis
Lindstrom U; Glintborg B; Di Giuseppe D; Nordstrom D; Provan SA; Gudbjornsson B; Askling J; Hetland ML; Aaltonen K; Krogh NS; Geirsson AJ; Jacobsson LTH
Article: RMD OPEN. 2019;5(2):e000978
Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study
Ilar A; Klareskog L; Saevarsdottir S; Wiebert P; Askling J; Gustaysson P; Alfredsson L
Article: JOURNAL OF CROHN'S AND COLITIS. 2018;12(12):1418-1428
Sick Leave and Disability Pension in Prevalent Patients With Crohn's Disease
Everhov AH; Khalili H; Askling J; Myrelid P; Ludvigsson JF; Halfvarson J; Nordenvall C; Soderling J; Olen O; Neovius M
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47(6):465-474
Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries
Glintborg B; Lindstrom U; Aaltonen K; Kristianslund EK; Gudbjornsson B; Chatzidionysiou K; Askling J; Nordstrom D; Hetland ML; Di Giuseppe D; Dreyer L; Kristensen LE; Jorgensen TS; Eklund K; Grondal G; Ernestam S; Joensuu J; Tormanen MRK; Skydsgaard H; Hagfors J; Kvien TK; Lie E; Fagerli K; Geirsson AJ; Jonsson H; Provan SA; Krogh NS; Jacobsson LTH
Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2018;113(11):1711-1719
Pancreatic Cancer Following Acute Pancreatitis: A Population-based Matched Cohort Study
Sadr-Azodi O; Oskarsson V; Discacciati A; Askling J; Videhult P; Ekbom A
Article: JAMA NETWORK OPEN. 2018;1(6):e183567
Risk of Thyroxine-Treated Autoimmune Thyroid Disease Associated With Disease Onset in Patients With Rheumatoid Arthritis
Waldenlind K; Saevarsdottir S; Bengtsson C; Askling J
Article: ARTHRITIS CARE AND RESEARCH. 2018;70(10):1563-1567
Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study
de Vries MK; Arkema EV; Jonsson J; Bruchfeld J; Jacobsson LTH; Askling J
Article: ANNALS OF INTERNAL MEDICINE. 2018;169(5):291-299
Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis A Nationwide Population-Based Cohort Study
Raaschou P; Soderling J; Turesson C; Askling J
Article: ARTHRITIS RESEARCH & THERAPY. 2018;20(1):175
Mediterranean diet and risk of rheumatoid arthritis: a population-based case-control study
Johansson K; Askling J; Alfredsson L; Di Giuseppe D
Article: EUROPEAN RESPIRATORY JOURNAL. 2018;52(2):1800385
Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study
Rossides M; Grunewald J; Eklund A; Kullberg S; Di Giuseppe D; Askling J; Arkema EV
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47(4):270-275
Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis
Baecklund E; Backlin C; Ronnelid J; Toes R; Huizinga TWJ; Ahlin E; Askling J; Hochberg FH; Klareskog L; Kay J; Smedby KE
Article: EXPERT OPINION ON BIOLOGICAL THERAPY. 2018;18(5):499-504
Uptake of rheumatology biosimilars in the absence of forced switching
Di Giuseppe D; Frisell T; Ernestam S; Forsblad-D'Elia H; Lindqvist E; Lindstrom U; Sjowall C; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(5):650-657
Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics
Frisell T; Baecklund E; Bengtsson K; Di Giuseppe D; Forsblad-d'Elia H; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(4):541-548
Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden
Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindstrom U; Askling J; Jacobsson LTH
Article: EUROPEAN RESPIRATORY JOURNAL. 2018;51(2):1701815
Sarcoidosis mortality in Sweden: a population-based cohort study
Rossides M; Kullberg S; Askling J; Eklund A; Grunewald J; Arkema EV
Article: GASTROENTEROLOGY. 2018;154(3):518-528.e15
Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden
Everhov AH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Soderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olen O
Article: JOURNAL OF CROHN'S AND COLITIS. 2018;12(2):157-166
Surgical Treatment in Childhood-onset Inflammatory Bowel Disease-A Nationwide Register-based Study of 4695 Incident Patients in Sweden 2002-2014
Nordenvall C; Rosvall O; Bottai M; Everhov AH; Malmborg P; Smedby KE; Ekbom A; Askling J; Ludvigsson JF; Myrelid P; Olen O
Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(1):85-91
Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?
Holmqvist M; Ljung L; Askling J
Article: RMD OPEN. 2018;4(2):e000762
Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study
Lindstrom U; Olofsson T; Wedren S; Qirjazo I; Askling J
Article: RMD OPEN. 2018;4(2):e000771
Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation
Ljung L; Ueda P; Liao KP; Greenberg JD; Etzel CJ; Solomon DH; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(12):2017-2024
Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis
Mantel A; Holmqvist M; Jernberg T; Wallberg-Jonsson S; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(12):2025-2030
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project
Mercer LK; Regierer AC; Mariette X; Dixon WG; Baecklund E; Hellgren K; Dreyer L; Hetland ML; Cordtz R; Hyrich K; Strangfeld A; Zink A; Canhao H; Victoria Hernandez M; Tubach F; Gottenberg J-E; Morel J; Zavada J; Iannone F; Askling J; Listing J
Article: JAMA INTERNAL MEDICINE. 2017;177(11):1605-1612
Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice A Nationwide Cohort Study From Sweden
Wadstroem H; Frisell T; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(11):1809-1814
Juvenile onset arthritis and pregnancy outcome: a population-based cohort study
Remaeus K; Johansson K; Askling J; Stephansson O
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(10):1642-1647
Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks
Holmqvist M; Ljung L; Askling J
Article: THE BMJ. 2017;358:j3951
Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014
Olen O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(9):1515-1521
Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register
Lie E; Lindstrom U; Zverkova-Sandstrom T; Olsen IC; Forsblad-d'Elia H; Askling J; Kapetanovic MC; Kristensen LE; Jacobsson LTH
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2017;46(6):589-598
Anti-TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study
Eberhardson M; Soderling JK; Neovius M; Cars T; Myrelid P; Ludvigsson JF; Askling J; Ekbom A; Olen O
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(7):1245-1252
Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?
Olofsson T; Petersson IF; Eriksson JK; Englund M; Nilsson JA; Geborek P; Jacobsson LTH; Askling J; Neovius M
Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):102
Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study
Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindstrom U; Askling J; Jacobsson LTH
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;185(8):681-687
Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma
Baecklund F; Foo J-N; Askling J; Eloranta S; Glimelius I; Liu J; Hjalgrim H; Rosenquist R; Padyukov L; Smedby KE
Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(4):700-708
Rheumatoid Arthritis and Risk of Malignant Lymphoma
Hellgren K; Baecklund E; Backlin C; Sundstrom C; Smedby KE; Askling J
Article: RHEUMATOLOGY. 2017;56(4):613-619
Cervical neoplasia in systemic lupus erythematosus: a nationwide study
Wadstrom H; Arkema EV; Sjowall C; Askling J; Simard JF
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2017;69(10):1275-1285
Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure
Mantel A; Holmqvist M; Andersson DC; Lund LH; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(2):364-370
Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?
Eriksson JK; Jacobsson L; Bengtsson K; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(2):386-391
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
Mercer LK; Askling J; Raaschou P; Dixon WG; Dreyer L; Hetland ML; Strangfeld A; Zink A; Mariette X; Finckh A; Canhao H; Lannone F; Zavada J; Morel J; Gottenberg J-E; Hyrich KL; Listing J
Article: BMC GASTROENTEROLOGY. 2017;17(1):23
Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study
Ludvigsson JF; Busch K; Olen O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
Article: RMD OPEN. 2017;3(2):e000498
Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.
Yamanaka H; Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Novelli Horne L; Inoue E; Michaud K; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SMM; Wesby-van Swaay E; Nyberg F
Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(1):143-147
Sex Ratio of Offspring Born to Women With Systemic Lupus Erythematosus or Rheumatoid Arthritis
Arkema EV; Askling J; Salmon JE; Simard JF
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(1):119-125
How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins
Hensvold AH; Frisell T; Magnusson PKE; Holmdahl R; Askling J; Catrina AI
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(1):105-111
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers
Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LTH; Kristensen L-E; Feltelius N; Hetland ML; Askling J
Article: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):288
A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy - results from a Swedish cohort study
Jiang X; Askling J; Saevarsdottir S; Padyukov L; Alfredsson L; Viatte S; Frisell T
Article: EUROPEAN RESPIRATORY JOURNAL. 2016;48(6):1690-1699
Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden
Arkema EV; Grunewald J; Kullberg S; Eklund A; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(12):2087-2094
Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis
Ljung L; Rantapaeae-Dahlqvist S; Jacobsson LTH; Askling J
Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2016;111(11):1614-1620
Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study
Khalili H; Neovius M; Ekbom A; Ludvigsson JF; Askling J; Chan AT; Olen O
Article: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):240
Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study
Lindstrom U; Exarchou S; Lie E; Dehlin M; Forsblad-d'Elia H; Askling J; Jacobsson L
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(10):1797-1805
Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease
Michaud K; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Nyberg F; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SMM; Wesby-van Swaay E; Yamanaka H; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(10):1789-1796
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries
Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Michaud K; Nyberg F; Pappas DA; Reed G; Tanaka E; Tran TN; Verstappen SMM; Yamanaka H; Wesby-van Swaay E; Symmons D
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(10):1838-1842
Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study
Jakobsson GL; Stephansson O; Askling J; Jacobsson LTH
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(8):1466-1472
Mortality in ankylosing spondylitis: results from a nationwide population-based study
Exarchou S; Lie E; Lindstrom U; Askling J; Forsblad-d'Elia H; Turesson C; Kristensen LE; Jacobsson LTH
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(7):1272-1278
Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden
Wadstrom H; Frisell T; Sparen P; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(6):1120-1125
Does a family history of RA influence the clinical presentation and treatment response in RA?
Frisell T; Saevarsdottir S; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(5):862-866
What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer?
Simard JF; Ekberg S; Johansson ALV; Askling J
Article: RHEUMATOLOGY. 2016;55(4):729-734
Does disease activity at start of biologic therapy influence work-loss in RA patients?
Olofsson T; Johansson K; Eriksson JK; van Vollenhoven R; Miller H; Petersson IF; Askling J; Neovius M
Article: THE BMJ. 2016;352:i262
Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden
Raaschou P; Simard JF; Hagelberg CA; Askling J
Article: ARTHRITIS RESEARCH & THERAPY. 2016;18:16
Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers
Lindstrom U; Forsblad-d'Elia H; Askling J; Kristensen LE; Lie E; Exarchou S; Jacobsson L
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(1):183-189
Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden
Frisell T; Hellgren K; Alfredsson L; Raychaudhuri S; Klareskog L; Askling J
Article: PLOS ONE. 2016;11(5):e0155956
Prevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: A Swedish Population Based Case-Control Study
Eriksson K; Nise L; Kats A; Luttropp E; Catrina AI; Askling J; Jansson L; Alfredsson L; Klareskog L; Lundberg K; Yucel-Lindberg T
Article: MULTIPLE SCLEROSIS JOURNAL. 2016;22(1):85-93
Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis
Frisell T; Forsberg L; Nordin N; Kiesel C; Alfredsson L; Askling J; Hillert J; Olsson T; Piehl F
Article: EUROPEAN HEART JOURNAL. 2015;36(48):3413-3422
Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome
Mantel A; Holmqvist M; Jernberg T; Wallberg-Jonsson S; Askling J
Article: ARTHRITIS CARE AND RESEARCH. 2015;67(12):1637-1645
Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries
Verstappen SMM; Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Holmqvist M; Horne L; Lampl K; Michaud K; Nyberg F; Pappas DA; Reed G; Symmons DPM; Tanaka E; Tran TN; Yamanaka H; Ho M
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(12):2137-2143
TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study
Raaschou P; Frisell T; Askling J
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(6):431-437
Effectiveness and survival-on-drug of certolizumab pegol in rheumatoid arthritis in clinical practice: results from the national Swedish register
Chatzidionysiou K; Kristensen L-E; Eriksson J; Askling J; van Vollenhoven R
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2015;49(6):486-491
Surgical interventions for nephrolithiasis in ankylosing spondylitis and the general population
Jakobsen AK; Jacobsson LTH; Patschan O; Hopfgarten T; Askling J; Kristensen LE
Article: ARTHRITIS & RHEUMATOLOGY. 2015;67(11):2845-2854
Risk Factors for the Rapid Increase in Risk of Acute Coronary Events in Patients With New-Onset Rheumatoid Arthritis: A Nested Case-Control Study
Mantel A; Holmqvist M; Nyberg F; Tornling G; Frisell T; Alfredsson L; Askling J
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2015;24(11):1121-1132
Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach
Nyberg F; Askling J; Berglind N; Franzen S; Ho M; Holmqvist M; Horne L; Lampl K; Michaud K; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SMM; Wesby-van Swaay E; Yamanaka H; Greenberg JD
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(5):369-376
Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register
Lindstrom U; Exarchou S; Sigurdardottir V; Sundstrom B; Askling J; Eriksson JK; Forsblad-d'Elia H; Turesson C; Kristensen LE; Jacobsson L
Article: ARTHRITIS CARE AND RESEARCH. 2015;67(9):1219-1229
Consistency and Utility of Data Items Across European Rheumatoid Arthritis Clinical Cohorts and Registers
Radner H; Dixon W; Hyrich K; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(8):1522-1529
Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history
Sparks JA; Chen C-Y; Jiang X; Askling J; Hiraki LT; Malspeis S; Klareskog L; Alfredsson L; Costenbader KH; Karlson EW
Article: RHEUMATOLOGY. 2015;54(8):1472-1477
Does disease activity at the start of biologic therapy influence health care costs in patients with RA?
Johansson K; Eriksson JK; van Vollenhoven R; Miller H; Askling J; Neovius M
Article: ARTHRITIS CARE AND RESEARCH. 2015;67(8):1137-1149
Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study
Kristensen LE; Jakobsen AK; Askling J; Nilsson F; Jacobsson LTH
Article: RHEUMATOLOGY. 2015;54(6):1074-1079
The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers
Kearsley-Fleet L; Zavada J; Hetland ML; Nordstroem DC; Aaltonen KJ; Listing J; Zink A; Gati T; Rojkovich B; Iannone F; Gremese E; van Riel PLCM; van de Laar MAFJ; Lie E; Kvien TK; Canhao H; Fonseca JE; Rotar Z; Loza E; Carmona L; Askling J; Johansson K; Finckh A; Dixon WG; Hyrich KL
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(6):1212-1217
Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?
Arkema EV; Jonsson J; Baecklund E; Bruchfeld J; Feltelius N; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(6):970-978
The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study
Lie E; Kristensen LE; Forsblad-d'Elia H; Zverkova-Sandstrom T; Askling J; Jacobsson LT
Article: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):118
The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study
Exarchou S; Lindstrom U; Askling J; Eriksson JK; Forsblad-d'Elia H; Neovius M; Turesson C; Kristensen LE; Jacobsson LTH
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(5):890-896
Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register
Chatzidionysiou K; Askling J; Eriksson J; Kristensen LE; van Vollenhoven R
Article: JOURNAL OF INTERNAL MEDICINE. 2015;277(5):594-604
The autoimmune spectrum of myasthenia gravis: a Swedish population-based study
Fang F; Sveinsson O; Thormar G; Granqvist M; Askling J; Lundberg IE; Ye W; Hammarstrom L; Pirskanen R; Piehl F
Article: JOURNAL OF RHEUMATOLOGY. 2015;42(4):690-694
Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome
Knight A; Hjorton K; Sundstrom C; Hoglund M; Backlin C; Smedby KE; Askling J; Baecklund E
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(4):648-654
Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
Eriksson JK; Johansson K; Askling J; Neovius M
Article: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):40
Physical activity and risk of rheumatoid arthritis in women: a population-based prospective study
Di Giuseppe D; Bottai M; Askling J; Wolk A
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(2):354-360
Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
Neovius M; Arkema EV; Olsson H; Eriksson JK; Kristensen LE; Simard JF; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(2):375-380
Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins
Hensvold AH; Magnusson PKE; Joshua V; Hansson M; Israelsson L; Ferreira R; Jakobsson P-J; Holmdahl R; Hammarstrom L; Malmstrom V; Askling J; Klareskog L; Catrina AI
Article: ARTHRITIS & RHEUMATOLOGY. 2015;67(2):352-362
To What Extent Is the Familial Risk of Rheumatoid Arthritis Explained by Established Rheumatoid Arthritis Risk Factors?
Jiang X; Frisell T; Askling J; Karlson EW; Klareskog L; Alfredsson L; Kallberg H
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(1):22-28
How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?
Wadstrom H; Eriksson JK; Neovius M; Askling J
Article: BMC MUSCULOSKELETAL DISORDERS. 2014;15:432
Validation of the rheumatoid arthritis diagnosis in the Swedish National patient register: a cohort study from Stockholm County
Waldenlind K; Eriksson JK; Grewin B; Askling J
Article: SCHIZOPHRENIA BULLETIN. 2014;40(6):1552-1559
The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risks.
Sellgren C; Frisell T; Lichtenstein P; Landèn M; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(11):1949-1953
Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women
Di Giuseppe D; Wallin A; Bottai M; Askling J; Wolk A
Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2014;32(5 Suppl 85):S-147-9
The Swedish Rheumatology Quality Register: optimisation of rheumatic disease assessments using register-enriched data.
Eriksson JK; Askling J; Arkema EV
Article: ARTHRITIS RESEARCH & THERAPY. 2014;16(3):R127
The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study
Ljung L; Askling J; Rantapaa-Dahlqvist S; Jacobsson L
Article: BMC CANCER. 2014;14:391
Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden
Holmes MD; Olsson H; Pawitan Y; Holm J; Lundholm C; Andersson TM-L; Adami H-O; Askling J; Smedby KE
Article: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(5):845-853
Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort
Olofsson T; Petersson IF; Eriksson JK; Englund M; Simard JF; Nilsson J-A; Geborek P; Jacobsson LTH; Askling J; Neovius M
Article: ARTHRITIS & RHEUMATOLOGY. 2014;66(5):1282-1290
Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden
Hellgren K; Smedby KE; Backlin C; Sundstrom C; Feltelius N; Eriksson JK; Baecklund E; Askling J
Article: JOURNAL OF INTERNAL MEDICINE. 2014;275(2):172-190
Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up
Persson I; Granath F; Askling J; Ludvigsson JF; Olsson T; Feltelius N
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2014;39(1):57-68
Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study
Busch K; Ludvigsson JF; Ekstrom-Smedby K; Ekbom A; Askling J; Neovius M
Article: PLOS ONE. 2014;9(11):e113602
Is Nephrolithiasis an Unrecognized Extra-Articular Manifestation in Ankylosing Spondylitis? A Prospective Population-Based Swedish National Cohort Study with Matched General Population Comparator Subjects
Jakobsen AK; Jacobsson LTH; Patschan O; Askling J; Kristensen LE
Article: ARTHRITIS & RHEUMATOLOGY. 2013;65(11):2773-2782
Familial Risks and Heritability of Rheumatoid Arthritis Role of Rheumatoid Factor/Anti-Citrullinated Protein Antibody Status, Number and Type of Affected Relatives, Sex, and Age
Frisell T; Holmqvist M; Kallberg H; Klareskog L; Alfredsson L; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(10):1675-1679
Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study
Kristensen LE; Englund M; Neovius M; Askling J; Jacobsson LTH; Petersson IF
Article: ARTHRITIS CARE AND RESEARCH. 2013;65(6):870-878
Incidence of Rheumatoid Arthritis in Sweden: A Nationwide Population-Based Assessment of Incidence, Its Determinants, and Treatment Penetration
Eriksson JK; Neovius M; Ernestam S; Lindblad S; Simard JF; Askling J
Article: ARTHRITIS CARE AND RESEARCH. 2013;65(5):678-685
Increased Risk of Arthropathies and Joint Replacement Surgery in Patients With Genetic Hemochromatosis: A Study of 3,531 Patients and Their 11,794 First-Degree Relatives
Elmberg M; Hultcrantz R; Simard JF; Carlsson A; Askling J
Article: ARTHRITIS RESEARCH & THERAPY. 2013;15(2):R56
Cigarette smoking and smoking cessation in relation to risk of rheumatoid arthritis in women
Di Giuseppe D; Orsini N; Alfredsson L; Askling J; Wolk A
Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(4):541-546
Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis
Holmqvist M; Gransmark E; Mantel A; Alfredsson L; Jacobsson LTH; Wallberg-Jonsson S; Askling J
Article: PLOS GENETICS. 2013;9(3):e1003394
Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis
Cui J; Stahl EA; Saevarsdottir S; Miceli C; Diogo D; Trynka G; Raj T; Mirkov MU; Canhao H; Ikari K; Terao C; Okada Y; Wedren S; Askling J; Yamanaka H; Momohara S; Taniguchi A; Ohmura K; Matsuda F; Mimori T; Gupta N; Kuchroo M; Morgan AW; Isaacs JD; Wilson AG; Hyrich KL; Herenius M; Doorenspleet ME; Tak P-P; Crusius JBA; van der Horst-Bruinsma IE; Wolbink GJ; van Riel PLCM; van de Laar M; Guchelaar H-J; Shadick NA; Allaart CF; Huizinga TWJ; Toes REM; Kimberly RP; Bridges SLJ; Criswell LA; Moreland LW; Fonseca JE; de Vries N; Stranger BE; De Jager PL; Raychaudhuri S; Weinblatt ME; Gregersen PK; Mariette X; Barton A; Padyukov L; Coenen MJH; Karlson EW; Plenge RM
Article: LAKARTIDNINGEN. 2013;110(3):82-84
[Observational cohort studies. Overview and some examples from the field of drug safety].
Holmqvist M; Raaschou P; Neovius M; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(11):1865-1867
Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study
Arkema EV; van Vollenhoven RF; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2012;64(11):3502-3510
Mortality Rates in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors Drug-Specific Comparisons in the Swedish Biologics Register
Simard JF; Neovius M; Askling J
Article: JOURNAL OF RHEUMATOLOGY. 2012;39(8):1583-1602
Canadian Rheumatology Association Recommendations for the Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs: Part II Safety
Bombardier C; Hazlewood GS; Akhavan P; Schieir O; Dooley A; Haraoui B; Khraishi M; Leclercq SA; Legare J; Mosher DP; Pencharz J; Pope JE; Thomson J; Thorne C; Zummer M; Gardam MA; Askling J; Bykerk V
Article: THE BMJ. 2012;345:e4230
Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study
Di Giuseppe D; Alfredsson L; Bottai M; Askling J; Wolk A
Article: JOURNAL OF INTERNAL MEDICINE. 2012;272(1):45-54
Risk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based study
Elmberg M; Hultcrantz R; Simard JF; Stal P; Pehrsson K; Askling J
Article: DIGESTIVE AND LIVER DISEASE. 2011;43(11):862-868
Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype
Olen O; Askling J; Ludvigsson JF; Hildebrand H; Ekbom A; Smedby KE
Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(8):1407-1414
Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice
Neovius M; Simard JF; Klareskog L; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(7):1812-1822
Does Cancer That Occurs During or After Anti-Tumor Necrosis Factor Therapy Have a Worse Prognosis? A National Assessment of Overall and Site-Specific Cancer Survival in Rheumatoid Arthritis Patients Treated With Biologic Agents
Raaschou P; Simard JF; Neovius M; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(6):1010-1015
How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?
Neovius M; Simard JF; Askling J
Article: INFLAMMATORY BOWEL DISEASES. 2011;17(5):1101-1107
Colitis-associated DNA Aneuploidy and Dysplasia in Crohn's Disease and Risk of Colorectal Cancer
Soderlund S; Tribukait B; Ost A; Brostrom O; Karlen P; Lofberg R; Askling J; Sjoqvist U
Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(4):624-629
Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden
Neovius M; Simard JF; Askling J
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2011;103(5):436-444
Risk of Lymphoproliferative Malignancy in Relation to Small Intestinal Histopathology Among Patients With Celiac Disease
Elfstrom P; Granath F; Smedby KE; Montgomery SM; Askling J; Ekbom A; Ludvigsson JF
Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(3):516-519
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
Neovius M; Simard JF; Sundstrom A; Jacobsson L; Geborek P; Saxne T; Feltelius N; Klareskog L; Askling J
Article: CIRCULATION. 2011;123(5):483-U239
Nationwide Cohort Study of Risk of Ischemic Heart Disease in Patients With Celiac Disease
Ludvigsson JF; James S; Askling J; Stenestrand U; Ingelsson E
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2011;20(2):119-130
Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
Askling J; Fahrbach K; Nordstrom B; Ross S; Schmid CH; Symmons D
Article: RHEUMATOLOGY. 2011;50(1):204-213
Ten years with biologics: to whom do data on effectiveness and safety apply?
Simard JF; Arkema EV; Sundstrom A; Geborek P; Saxne T; Baecklund E; Coster L; Dackhammar C; Jacobsson L; Feltelius N; Lindblad S; Rantapaa-Dahlqvist S; Klareskog L; van Vollenhoven RF; Neovius M; Askling J
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2011;40(1):8-15
Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009
Neovius M; Sundstrom A; Simard JF; Wettermark B; Cars T; Feltelius N; Askling J; Klareskog L
Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(1):26-36
Patients With Early Rheumatoid Arthritis Who Smoke Are Less Likely to Respond to Treatment With Methotrexate and Tumor Necrosis Factor Inhibitors Observations From the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register Cohorts
Saevarsdottir S; Wedren S; Seddighzadeh M; Bengtsson C; Wesley A; Lindblad S; Askling J; Alfredsson L; Klareskog L
Article: RHEUMATOLOGY. 2011;50(1):146-151
Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers
Strangfeld A; Hyrich K; Askling J; Arkema E; Davies R; Listing J; Neovius M; Simard J; Symmons D; Watson K; Zink A
Article: JOURNAL OF RHEUMATOLOGY. 2010;37(12):2553-2558
Increased Risk of Autoimmune Disease in Families with Wegener's Granulomatosis
Knight A; Sandin S; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(12):3776-3782
Juvenile Idiopathic Arthritis and Risk of Cancer A Nationwide Cohort Study
Simard JF; Neovius M; Hagelberg S; Askling J
Article: JOURNAL OF INTERNAL MEDICINE. 2010;268(6):578-585
Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006
Holmqvist ME; Wedren S; Jacobsson LTH; Klareskog L; Nyberg F; Rantapaa-Dahlqvist S; Alfredsson L; Askling J
Article: JOURNAL OF INTERNAL MEDICINE. 2010;268(4):329-337
Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study
Norgaard M; Larsson H; Pedersen L; Granath F; Askling J; Kieler H; Ekbom A; Sorensen HT; Stephansson O
Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(9):1596-1602
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
Dixon WG; Carmona L; Finckh A; Hetland ML; Kvien TK; Landewe R; Listing J; Nicola PJ; Tarp U; Zink A; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(7):1849-1861
Rheumatoid Arthritis Risk Allele PTPRC Is Also Associated With Response to Anti-Tumor Necrosis Factor α Therapy
Cui J; Saevarsdottir S; Thomson B; Padyukov L; van der Helm-van Mil AHM; Nititham J; Hughes LB; de Vries N; Raychaudhuri S; Alfredsson L; Askling J; Wedren S; Ding B; Guiducci C; Wolbink GJ; Crusius JBA; van der Horst-Bruinsma IE; Herenius M; Weinblatt ME; Shadick NA; Worthington J; Batliwalla F; Kern M; Morgan AW; Wilson AG; Isaacs JD; Hyrich K; Seldin MF; Moreland LW; Behrens TW; Allaart CF; Criswell LA; Huizinga TWJ; Tak PP; Bridges SLJ; Toes REM; Barton A; Klareskog L; Gregersen PK; Karlson EW; Plenge RM
Article: JOURNAL OF CYSTIC FIBROSIS. 2010;9(4):288-291
Cystic fibrosis gene mutations and gastrointestinal diseases
Bahmanyar S; Ekbom A; Askling J; Johannesson M; Montgomery SM
Article: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2010;181(11):1217-1222
Smoking, Use of Moist Snuff, and Risk of Chronic Inflammatory Diseases
Carlens C; Hergens M-P; Grunewald J; Ekbom A; Eklund A; Hoglund CO; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(5):1252-1258
Do Rheumatoid Arthritis and Lymphoma Share Risk Factors? A Comparison of Lymphoma and Cancer Risks Before and After Diagnosis of Rheumatoid Arthritis
Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
Article: GASTROENTEROLOGY. 2010;138(5):1697-16U6
Inflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to Males
Soderlund S; Granath F; Brostrom O; Karlen P; Lofberg R; Ekbom A; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(4):654-659
Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study
Hellgren K; Iliadou A; Rosenquist R; Feltelius N; Backlin C; Enblad G; Askling J; Baecklund E
Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(4):737-740
Occupational risk factors for Wegener's granulomatosis: a case-control study
Knight A; Sandin S; Askling J
Article: HEPATOLOGY. 2010;51(2):595-602
Decreased Survival of Subjects with Elevated Liver Function Tests During a 28-Year Follow-Up
Soderberg C; Stal P; Askling J; Glaumann H; Lindberg G; Marmur J; Hultcrantz R
Article: ARTHRITIS RESEARCH & THERAPY. 2010;12(2):R67
Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
Simon TA; Askling J; Lacaille D; Franklin J; Wolfe F; Covucci A; Suissa S; Hochberg MC
Article: INTERNATIONAL JOURNAL OF CANCER. 2009;125(12):2953-2956
Cancer risk among patients with cystic fibrosis and their first-degree relatives
Johannesson M; Askling J; Montgomery SM; Ekbom A; Bahmanyar S
Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(12):1819-1826
Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
Simon TA; Smitten AL; Franklin J; Askling J; Lacaille D; Wolfe F; Hochberg MC; Qi K; Suissa S
Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(10):2861-2869
No Increased Occurrence of Ischemic Heart Disease Prior to the Onset of Rheumatoid Arthritis Results From Two Swedish Population-Based Rheumatoid Arthritis Cohorts
Holmqvist ME; Wedren S; Jacobsson LTH; Klareskog L; Nyberg F; Rantapaa-Dahlqvist S; Alfredsson L; Askling J
Article: GASTROENTEROLOGY. 2009;137(4):1301-1309
Increased Mortality Risk in Patients With Phenotypic Hereditary Hemochromatosis But Not in Their First-Degree Relatives
Elmberg M; Hultcrantz R; Ebrahim F; Olsson S; Lindgren S; Loof L; Stal P; Wallerstedt S; Almer S; Sandberg-Gertzen H; Ekbom A; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(7):1159-1164
Perinatal characteristics, early life infections and later risk of rheumatoid arthritis and juvenile idiopathic arthritis
Carlens C; Jacobsson L; Brandt L; Cnattingius S; Stephansson O; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(5):648-653
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Coster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapaa-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
Article: GASTROENTEROLOGY. 2009;136(5):1561-1567
Decreasing Time-Trends of Colorectal Cancer in a Large Cohort of Patients With Inflammatory Bowel Disease
Soderlund S; Brandt L; Lapidus A; Karlen P; Brostrom O; Lofberg R; Ekbom A; Askling J
Article: MULTIPLE SCLEROSIS JOURNAL. 2009;15(4):431-436
Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis
Nielsen TR; Rostgaard K; Askling J; Steffensen R; Oturai A; Jersild C; Koch-Henriksen N; Sorensen PS; Hjalgrim H
Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(3):653-660
Specific Association of Type 1 Diabetes Mellitus With Anti-Cyclic Citrullinated Peptide-Positive Rheumatoid Arthritis
Liao KP; Gunnarsson M; Kallberg H; Ding B; Plenge RM; Padyukov L; Karlson EW; Klareskog L; Askling J; Alfredsson L
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2008;6(8):939-943
Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis
Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Loof L; Sandberg-Gertzen H; Almer S; Askling J; Ehlin A; Ekbom A
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2008;43(8):961-966
Early-life exposures associated with antibiotic use and risk of subsequent Crohn's disease
Hildebrand H; Malmborg P; Askling J; Ekbom A; Montgomery SM
Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2008;26(3):S53-S56
What is the significance in routine care of c-ANCA/PR3-ANCA in the absence of systemic vasculitis? A case series
Knight A; Ekbom A; Brandt L; Askling J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2008;141(1):69-72
Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis
Baecklund E; Natkunam Y; Backlin C; Iliadou A; Askling J; Ekbom A; Feltelius N; Klareskog L; Enblad G; Lossos IS; Levy R; Sundstroem C; Rosenquist R
Article: ARTHRITIS & RHEUMATOLOGY. 2008;58(1):302-307
Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease
Knight A; Sandin S; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(10):1339-1344
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Feltelius N; Coster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapaa-Dahlqvist S; Saxne T; van Vollenhoven RF; Klareskog L
Article: EUROPEAN RESPIRATORY JOURNAL. 2007;30(3):414-422
Influenza vaccination and mortality:: prospective cohort study of the elderly in a large geographical area
Oertqvist A; Granath F; Askling J; Hedlund J
Article: INFLAMMATORY BOWEL DISEASES. 2007;13(5):531-536
Potential role for the common cystic fibrosis AF508 mutation in Crohn's disease
Bresso F; Askling J; Astegiano M; Demarchi B; Sapone N; Rizzetto M; Gionchetti P; Lammers KM; de Leone A; Riegler G; Nimmo ER; Drummond H; Noble C; Torkvist L; Ekbom A; Zucchelli M; Lofberg R; Satsangi J; Pettersson S; D'Amato M
Article: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(3):414-416
The inflammatory reflex and risk for rheumatoid arthritis: a case-control study of human vagotomy
Carlens C; Brandt L; Klareskog L; Lampa J; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2006;54(12):3774-3781
Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis
Baecklund E; Backlin C; Iliadou A; Granath F; Ekbom A; Amini R-M; Feltelius N; Enblad G; Sundstrom C; Klareskog L; Askling J; Rosenquist R
Article: DIGESTIVE AND LIVER DISEASE. 2006;38(11):823-828
Diagnosis underlying appendectomy and coeliac disease risk
Ludvigsson JF; Askling J; Ekbom A; Montgomery SM
Article: JOURNAL OF RHEUMATOLOGY. 2006;33(10):2060-2063
Increasing incidence of Wegener's granulomatosis in Sweden, 1975-2001
Knight A; Ekbom A; Brandt L; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(9):1184-1187
Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study
Askling J; Klareskog L; Blomqvist P; Fored M; Feltelius N
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2006;15(7):1295-1300
Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was
Sandin S; Hjalgrim H; Glimelius B; Rostgaard K; Pukkala E; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(6):741-745
Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis
Björnådal L; Brandt L; Klareskog L; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2006;54(3):692-701
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
Baecklund E; Iliadou A; Askling J; Ekborn A; Backlin C; Granath F; Catrina AT; Rosenquist R; Feltelius N; Sundström C; Klareskog L
Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(2):449-452
Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-onset Hodgkin lymphoma
Landgren O; Björkholm M; Montgomery SM; Hjalgrim H; Sjöberg J; Goldin LR; Askling J
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2006;98(1):51-60
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype
Smedby KE; Hjalgrim H; Askling J; T Chang E; Gregersen H; Porwit-MacDonald A; Sundström C; Åkerman M; Melbye M; Glimelius B; Adami HO
Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(12):1765-1768
Do steroids increase lymphoma risk?: A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis
Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(10):1414-1420
Haematopoietic malignancies in rheumatoid arthritis:: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
Askling J; Fored CM; Baecklund E; Brandt L; Backlin C; Ekbom A; Sundström C; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L; Feltelius N
Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(10):1421-1426
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Feltelus N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L
Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2005;23(5):S195-S200
Rheumatoid arthritis registries in Sweden
van Vollenhoven RF; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2005;52(7):1986-1992
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Romanus V; Klareskog L; Feltelius N
Article: GUT. 2005;54(5):617-622
Risk of haematopoietic cancer in patients with inflammatory bowel disease
Askling J; Brandt L; Lapidus A; Karlén P; Björkholm M; Löfberg R; Ekbom A
Article: GUT. 2005;54(1):54-59
Malignant lymphomas in coeliac disease:: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma
Smedby KE; Åkerman M; Hildebrand H; Glimelius B; Ekbom A; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2004;63(10):1307-1311
Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide
Knight A; Askling J; Granath F; Sparen P; Ekbom A
Article: INTERNATIONAL JOURNAL OF CANCER. 2004;110(5):763-766
Maternal breast cancer risk after the death of a child
Lambe M; Cerrato R; Askling J; Hsieh CC
Article: INTERNATIONAL JOURNAL OF CANCER. 2004;109(6):941-944
Women smoking and testicular cancer: One epidemic causing another?
Pettersson A; Kaijser M; Richiardi L; Askling J; Ekbom A; Akre O
Article: ACTA ONCOLOGICA. 2004;43(3):297-301
Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma
Ösby E; Askling J; Landgren O; Dickman PW; Ekbom A; Björkholm M
Article: GASTROENTEROLOGY. 2003;125(6):1733-1741
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Elmberg M; Hultcrantz R; Ekbom A; Brandt L; Olsson S; Olsson R; Lindgren S; Lööf L; Stål P; Wallerstedt S; Almer S; Sandberg-Gertzén H; Askling J
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2003;349(14):1324-1332
Characteristics of Hodgkin's lymphoma after infectious mononucleosis
Hjalgrim H; Askling J; Rostgaard K; Hamilton-Dutoit S; Frisch M; Zhang J; Madsen M; Rosdahl N; Konradsen HB; Storm HH; Melbye M
Article: GUT. 2003;52(10):1432-1434
Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001.
Hildebrand H; Finkel Y; Grahnquist L; Lindholm J; Ekbom A; Askling J
Article: ARCHIVES OF INTERNAL MEDICINE (CHICAGO, ILL. : 1908). 2003;163(13):1566-1572
Causes of death in patients with celiac disease in a population-based Swedish cohort
Peters U; Askling J; Gridley G; Ekbom A; Linet M
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2003;12(7):669-673
Body size at birth and adulthood and the risk for germ-cell testicular cancer
Richiardi L; Askling J; Granath F; Akre O
Article: PEDIATRICS. 2003;111(6):1343-1350
Appendectomy during childhood and adolescence and the subsequent risk of cancer in Sweden
Cope JU; Askling J; Gridley G; Mohr A; Ekbom A; Nyren O; Linet MS
Article: THE BMJ. 2003;326(7398):1068-1069
Perinatal characteristics and risk of rheumatoid arthritis
Jacobsson LTH; Jacobsson ME; Askling J; Knowler WC
Article: ARTHRITIS & RHEUMATOLOGY. 2003;48(4):963-970
Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives
Ekström K; Hjalgrim H; Brandt L; Baecklund E; Klareskog L; Ekbom A; Askling J
Article: GASTROENTEROLOGY. 2002;123(5):1428-1435
Cancer incidence in a population-based cohort of individuals hospitalized with Celiac disease or dermatitis herpetiformis
Askling J; Linet M; Gridley G; Halstensen TS; Ekström K; Ekbom A
Article: INTERNATIONAL JOURNAL OF CANCER. 2002;100(1):82-85
Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis
Knight A; Askling J; Ekbom A
Article: HAEMATOLOGICA. 2002;87(6):596-601
Parental longevity and survival in elderly patients with Hodgkin's lymphoma
Landgren O; Askling J; Dickman PW; Ösby E; Axdorph U; Ekbom A; Björkholm M
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2002;94(9):678-681
Hematopoietic and lymphatic cancers in relatives of patients with infectious mononucleosis
Hjalgrim H; Rostgaard K; Askling J; Madsen M; Storm HH; Rabkin CS; Melbye M
Article: THE LANCET. 2001;358(9278):297-298
Incidence of Hodgkin's disease in Nordic countries
Hjalgrim H; Askling J; Pukkala E; Hansen S; Munksgaard L; Frisch M
Article: GASTROENTEROLOGY. 2001;120(6):1356-1362
Family history as a risk factor for colorectal cancer in inflammatory bowel disease
Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
Article: THE LANCET. 2001;357(9252):262-266
Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease:: a population-based cohort study
Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
Article: BRITISH JOURNAL OF CANCER. 2001;84(1):113-115
Risk of non-Hodgkin's lymphoma following tuberculosis
Askling J; Ekbom A
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2000;92(18):1522-1528
Risk of Hodgkin's disease and other cancers after infectious mononucleosis
Hjalgrim H; Askling J; Sorensen P; Madsen M; Rosdahl N; Storm HH; Hamilton-Dutoit S; Eriksen LS; Frisch M; Ekbom A; Melbye M
Article: THE LANCET. 1999;354(9195):2053
Sickness in pregnancy and sex of child
Askling J; Erlandsson G; Kaijser M; Akre O; Ekbom A
Article: ANNALS OF INTERNAL MEDICINE. 1999;131(9):655-659
Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer?
Askling J; Sorensen P; Ekbom A; Frisch M; Melbye M; Glimelius B; Hjalgrim H
Article: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 1999;160(5):1668-1672
Increased risk for cancer following sarcoidosis
Askling J; Grunewald J; Eklund A; Hillerdal G; Ekbom A
Article: THE LANCET. 1999;354(9185):1179
Incidence of paediatric Crohn's disease in Stockholm, Sweden
Askling J; Grahnquist L; Ekbom A; Finkel Y
Visa fler

Alla övriga publikationer

Corrigendum: NATURE COMMUNICATIONS. 2023;14(1):3923
Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethality (vol 14, 3453, 2023)
Oddsson AR; Sulem P; Sveinbjornsson G; Arnadottir G; Steinthorsdottir VM; Halldorsson G; Atlason B; Oskarsson GO; Helgason H; Nielsen HS; Westergaard D; Karjalainen JA; Katrinardottir H; Fridriksdottir R; Jensson BB; Tragante V; Ferkingstad EA; Jonsson H; Gudjonsson S; Beyter D; Moore KHS; Thordardottir H; Kristmundsdottir S; Stefansson O; Rantapaeae-Dahlqvist S; Sonderby IE; Didriksen M; Stridh PA; Haavik J; Tryggvadottir L; Frei O; Walters GB; Kockum I; Hjalgrim H; Olafsdottir T; Selbaek G; Nyegaard M; Erikstrup C; Brodersen T; Saevarsdottir S; Olsson T; Nielsen KR; Haraldsson A; Bruun MT; Hansen TF; Steingrimsdottir TT; Jacobsen RL; Lie R; Djurovic S; Alfredsson L; Lopez de Lapuente Portilla A; Brunak SV; Melsted P; Halldorsson B; Saemundsdottir J; Magnusson OT; Padyukov L; Banasik K; Rafnar T; Askling J; Klareskog L; Pedersen OB; Masson G; Havdahl AA; Nilsson B; Andreassen O; Daly M; Ostrowski SR; Jonsdottir I; Stefansson H; Holm H; Helgason A; Thorsteinsdottir UF; Stefansson K; Gudbjartsson D
Letter: RHEUMATOLOGY. 2023;62(6):e204
Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis: reply
Westerlind H; Kastbom A; Askling J
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(4):e88
Response to: 'Correspondence on 'Risk of venous thromboembolism in rheumatoid arthritis and its association with disease activity: a nationwide cohort study from Sweden'' by Zervou et al
Molander V; Askling J
Corrigendum: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023;58:152141
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration (vol 56, 152081, 20222)
Ornbjerg LM; Linde L; Georgiadis S; Rasmussen SH; Lindstrom U; Askling J; Michelsen B; Di Giuseppe D; Wallman JK; Pavelka K; Zavada J; Nissen MJ; Jones GT; Relas H; Pirila L; Tomsic M; Rotar Z; Geirsson AJ; Gudbjornsson B; Kristianslund EK; van der Horst-Bruinsma I; Loft AG; Laas K; Iannone F; Corrado A; Ciurea A; Santos MJ; Santos H; Codreanu C; Akkoc N; Gunduz OS; Glintborg B; Ostergaard M; Hetland ML
Corrigendum: RHEUMATOLOGY. 2022;61(12):4998
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration (vol 9, keac081, 2022)
Delcoigne B; Provan SA; Hammer HB; Di Giuseppe D; Frisell T; Glintborg B; Grondal G; Gudbjornsson B; Hetland ML; Michelsen B; Nordstrom D; Relas H; Askling J
Editorial comment: ANIMAL CONSERVATION. 2022;25(5):612-613
Towards an improved evidence-based Natura 2000 management strategy
Kindvall O; Forsman A; Johansson V; Askling J; Franzen M
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(5):e74
Response to: 'Neuroinflammatory events after anti-TNFα therapy' by Kaltsonoudis et al
Kopp TI; Delcoigne B; Arkema EV; Magyari M; Locht H; Sellebjerg FT; Cordtz RL; Jensen DV; Askling J; Dreyer L
Letter: RHEUMATOLOGY. 2021;61(1):e31
Comment on: Incidence of extra-articular manifestations in AS, PsA and undifferentiated SpA: results from a national register-based cohort study. Reply
Bengtsson K; Forsblad-d'Elia H; Deminger A; Klingberg E; Dehlin M; Exarchou S; Lindstrom U; Askling J; Jacobsson LTH
Letter: GUT. 2021;70(5):998
Reply: Survival in Crohn's disease-associated small bowel adenocarcinoma
Axelrad JE; Olen O; Sachs MC; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sorensen HT; Ludvigsson JF
Review: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(6):685-699
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Smolen JS; Landewe RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M; Aletaha D; Aringer M; Askling J; Balsa A; Boers M; den Broeder AA; Buch MH; Buttgereit F; Caporali R; Cardiel MH; De Cock D; Codreanu C; Cutolo M; Edwards CJ; van Eijk-Hustings Y; Emery P; Finckh A; Gossec L; Gottenberg J-E; Hetland ML; Huizinga TWJ; Koloumas M; Li Z; Mariette X; Mueller-Ladner U; Mysler EF; da Silva JAP; Poor G; Pope JE; Rubbert-Roth A; Ruyssen-Witrand A; Saag KG; Strangfeld A; Takeuchi T; Voshaar M; Westhovens R; van der Heijde D
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):e50
Response to: 'Inflammatory and non-inflammatory triggers of acute coronary syndromes' by Eyuboglu
Westerlind H; Holmqvist M; Ljung L; Frisell T; Askling J
Letter: RESPIRATORY MEDICINE. 2019;160:105696
Correspondence for "Clinical epidemiology of familial sarcoidosis: A systematic literature review"
Rossides M; Grunewald J; Eklund A; Kullberg S; Askling J; Arkema EV
Review: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(9):1160-1166
2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis
Ehlers L; Askling J; Bijlsma HWJ; Cid MC; Cutolo M; Dasgupta B; Dejaco C; Dixon WG; Feltelius N; Finckh A; Gilbert K; Mackie SL; Mahr A; Matteson EL; Neill L; Salvarani C; Schmidt WA; Strangfeld A; van Vollenhoven RF; Buttgereit F
Letter: RHEUMATOLOGY. 2019;58(8):1510-1511
Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply
Frisell T; Askling J
Letter: RHEUMATOLOGY. 2019;58(8):1507-1509
Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply
Frisell T; Askling J
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(10):1536-1537
Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study
Just SA; Rostgaard K; Titlestad K; Edgren G; Erikstrup C; Ullum H; Pedersen OB; Nielsen KR; Askling J; Lindegaard H; Hjalgrim H
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(8):1236-1238
Seropositivity combined with smoking is associated with increased prevalence of periodontitis in patients with rheumatoid arthritis
Eriksson K; Nise L; Alfredsson L; Catrina AI; Askling J; Lundberg K; Klareskog L; Yucel-Lindberg T
Review: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(4):476-479
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis
Radner H; Chatzidionysiou K; Nikiphorou E; Gossec L; Hyrich KL; Zabalan C; van Eijk-Hustings Y; Williamson PR; Balanescu A; Burmester GR; Carmona L; Dougados M; Finckh A; Haugeberg G; Hetland ML; Oliver S; Porter D; Raza K; Ryan P; Santos MJ; van der Helm-van Mil A; van Riel P; von Krause G; Zavada J; Dixon WG; Askling J
Review: RMD OPEN. 2018;4(1):e000655
Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example
Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordstrom D; Aaltonen K; Tormanen MRK; Kristianslund EK; Kvien TK; Provan SA; Guobjornsson B; Dreyer L; Kristensen LE; Jorgensen TS; Jacobsson L; Askling J
Editorial comment: ARTHRITIS & RHEUMATOLOGY. 2017;69(8):1509-1511
Is Rheumatoid Arthritis a Mortal Disease?
Askling J; Holmqvist M; Ljung L
Review: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):251
Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature
Nikiphorou E; Radner H; Chatzidionysiou K; Desthieux C; Zabalan C; van Eijk-Hustings Y; Dixon WG; Hyrich KL; Askling J; Gossec L
Review: NATURE REVIEWS. RHEUMATOLOGY. 2016;12(6):335-343
Family history of rheumatoid arthritis: an old concept with new developments
Frisell T; Saevarsdottir S; Askling J
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(11):2061-2062
No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment
Arkema EV; Feltelius N; Olsson T; Askling J
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(6):e32
Response to: 'Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)' by Iannone et al
Neovius M; Askling J
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(3):628
Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries
Zavada J; Dixon WG; Askling J
Review: SEMINARS IN CANCER BIOLOGY. 2014;24:61-70
Lymphoma development in patients with autoimmune and inflammatory disorders - What are the driving forces?
Baecklund E; Smedby KE; Sutton L-A; Askling J; Rosenquist R
Letter: ARTHRITIS & RHEUMATOLOGY. 2013;65(6):1671-1672
Mortality rates among patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: comment on the article by Simard et al Reply
Simard JF; Neovius M; Askling J
Letter: CIRCULATION. 2011;124(16):E423
Response to Letter Regarding Article, "Nationwide Cohort Study of Risk of Ischemic Heart Disease in Patients With Celiac Disease"
Ludvigsson JF; James S; Askling J; Ingelsson E
Letter: LEUKEMIA AND LYMPHOMA. 2011;52(6):1146-1149
LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma
Baecklund E; Backlin C; Mansouri M; Klareskog L; Askling J; Iliadou AN; Enblad G; Lossos IS; Natkunam Y; Rosenquist R
Editorial comment: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(4):561-562
Influence of biological agents on cardiovascular disease in rheumatoid arthritis
Askling J; Dixon W
Review: ZEITSCHRIFT FUR RHEUMATOLOGIE. 2010;69(9):774-779
The risk of malignancies in RA patients treated with biologics
Askling J
Review: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2010;40(1):2-14.e1
A Comparison of Patient Characteristics and Outcomes in Selected European and US Rheumatoid Arthritis Registries
Curtis JR; Jain A; Askling J; Bridges SLJ; Carmona L; Dixon W; Finckh A; Hyrich K; Greenberg JD; Kremer J; Listing J; Michaud K; Mikuls T; Shadick N; Solomon DH; Weinblatt ME; Wolfe F; Zink A
Letter: ARTHRITIS & RHEUMATOLOGY. 2010;62(8):2561
Ischemic heart disease and rheumatoid arthritis: comment on the article by Holmqvist et al Reply
Holmqvist M; Askling J
Letter: GASTROENTEROLOGY. 2009;137(5):1858
Is Ulcerative Colitis Proctitis Associated With an Increased Risk of Colorectal Cancer? Reply
Soderlund S; Brandt L; Lapidus A; Karlen P; Brostrom O; Lofberg R; Ekbom A; Askling J
Review: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(8):1240-1246
European biologicals registers: methodology, selected results and perspectives
Zink A; Askling J; Dixon WG; Klareskog L; Silman AJ; Symmons DPM
Review: JOURNAL OF INTERNAL MEDICINE. 2008;264(6):514-527
Autoimmune and inflammatory disorders and risk of malignant lymphomas - an update
Smedby KE; Askling J; Mariette X; Baecklund E
Review: CURRENT OPINION IN RHEUMATOLOGY. 2008;20(3):334-339
Malignancy and biologic therapy in rheumatoid arthritis
Askling J; Bongartz T
Review: CURRENT OPINION IN RHEUMATOLOGY. 2008;20(2):138-144
The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
Askling J; Dixon W
Review: CURRENT RHEUMATOLOGY REPORTS. 2007;9(5):421-426
Malignancy and rheumatoid arthritis.
Askling J
Review: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2006;15(11):2069-2077
Malignant lymphomas in autoimmunity and inflammation: A review of risks, risk factors, and lymphoma characteristics
Ekstrom Smedby K; Baecklund E; Askling J
Review: CURRENT OPINION IN RHEUMATOLOGY. 2004;16(3):254-261
Rheumatoid arthritis and malignant lymphomas
Baecklund E; Askling J; Rosenquist R; Ekbom A; Klareskog L
Thesis / dissertation: 2001
Epidemiological studies of host susceptibility in malignant lymphomas and colorectal cancer
Askling, Johan
Visa fler

Anställningar

Professor/Överläkare, Medicin, Solna, Karolinska Institutet, 2013-

Examina och utbildning

Docent, Epidemiologi, Karolinska Institutet, 2005
MEDICINE DOKTORSEXAMEN, Institutionen för medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2001

Om mig

Utvalda publikationer

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI